SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?

Hitesh C Patel, Carl Hayward, Carlo Di Mario


Resistant hypertension is, by definition, a challenge to most physicians treating hypertension. Renal sympathetic denervation has shown promising early results in treating this condition. The SYMPLICITY HTN-3 is the most recent trial to report the effects of this technique on resistant hypertension. This review discusses this study and its surprising neutral results before ending with an overview of key lessons learned. 

Full Text:



  • There are currently no refbacks.

Copyright (c) 2017 Hitesh C Patel, Carl Hayward, Carlo Di Mario

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.